UBS Group initiated coverage on shares of Galapagos (NASDAQ:GLPG – Get Rating) in a report released on Wednesday morning, The Fly reports. The firm issued a neutral rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the stock. Royal Bank of Canada reduced their price target on shares […]
Finepoint Capital LP grew its position in shares of Galapagos NV (NASDAQ:GLPG – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,359 shares of the biotechnology company’s stock after acquiring an additional 10,657 shares during the […]
Finepoint Capital LP grew its position in shares of Galapagos NV (NASDAQ:GLPG – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,359 shares of the biotechnology company’s stock after acquiring an additional 10,657 shares during the […]
Several analysts have recently updated their ratings and price targets for Galapagos (NASDAQ: GLPG): 5/18/2023 – Galapagos is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/9/2023 – Galapagos had its price target lowered by analysts at Morgan Stanley from $44.00 to $42.00. 5/8/2023 – Galapagos was upgraded by […]
Investment analysts at StockNews.com assumed coverage on shares of Galapagos (NASDAQ:GLPG – Get Rating) in a report released on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. GLPG has been the topic of a number of other reports. Morgan Stanley cut their target price on Galapagos from $44.00 to $42.00 in […]